RSS   Newsletter   Contact   Advertise with us

Symic Bio appoints Hicham Alaoui as senior vice president

Share on Twitter Share on LinkedIn
Staff Writer | San Francisco, Ca., USA | January 23, 2018
Symic BioSymic Bio, a biopharmaceutical company, announced the appointment of Hicham Alaoui as senior vice president of discovery biology.
Dr. Alaoui most recently served as Director of Biochemical and Cellular Pharmacology at Genentech, a member of the Roche Group.

At Genentech, Dr. Alaoui was responsible for lead discovery and optimization, biomarker analysis and directing mechanism of action studies supporting small molecule and biotherapeutic research programs in multiple therapeutic areas.

Prior to Genentech, Dr. Alaoui has held the position of Director of Biology at Stryker Biotech, where he lead discovery and bioanalytical efforts in support of pre-clinical and clinical studies.

He has also held positions at VisEn Medical, NeoGenesis Pharmaceuticals and Shire.

Dr. Alaoui received his Ph.D. in Microbiology and Immunology from McGill University.